TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioLindh AB
Closing information (x1000 EUR)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
34
|
47
|
25 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
30
|
40
|
20 |
EBITDA |
27
|
40
|
20 |
Total assets |
134
|
109
|
76 |
Current assets |
134
|
109
|
76 |
Current liabilities |
23
|
25
|
20 |
Equity capital |
109
|
82
|
56 |
- share capital |
9
|
8
|
9 |
Employees (average) |
1
|
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
81.3%
|
75.2%
|
73.7% |
Turnover per employee | 34 | ||
Profit as a percentage of turnover |
88.2%
|
85.1%
|
80.0% |
Return on assets (ROA) |
22.4%
|
36.7%
|
26.3% |
Current ratio |
582.6%
|
436.0%
|
380.0% |
Return on equity (ROE) |
27.5%
|
48.8%
|
35.7% |
Change turnover |
-14
|
24
|
22 |
Change turnover % |
-29%
|
104%
|
715% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.